EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Medermycin Inhibits TNFα-Promoted Inflammatory Reaction in Human Synovial Fibroblasts

Sho Inoue, Yuki Inahashi, Makoto Itakura, Gen Inoue iD, Kyoko Muneshige, Tomoyasu Hirose iD, Masato Iwatsuki iD, Masashi Takaso, Masayuki Miyagi iD, Kentaro Uchida iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241813871 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Sho Inoue und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Kitasato University School of Medicine, 1-15-1 Minami-ku Kitasato, Sagamihara City 252-0374, Japan. Hauptthemen laut MEDLINE: Osteoarthritis, Tumor Necrosis Factor-alpha. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS KAKENHI, Research Support Project for Life Sciences Research and Drug Discovery, specifically the Basis for Supporting Innovative Drug Discovery and Life Science Resear…, All Kitasato Project Study (AKPS).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Synovial inflammation plays a crucial role in the destruction of joints and the experience of pain in osteoarthritis (OA). Emerging evidence suggests that certain antibiotic agents and their derivatives possess anti-inflammatory properties. Medermycin (MED) has been identified as a potent antibiotic, specifically active against Gram-positive bacteria. In this study, we aimed to investigate the impact of MED on TNFα-induced inflammatory reactions in a synovial cell line, SW-982, as well as primary human synovial fibroblasts (HSF) using RNA sequencing, rtRT-PCR, ELISA, and western blotting. Through the analysis of differentially expressed genes (DEGs), we identified a total of 1478 significantly upregulated genes in SW-982 cells stimulated with TNFα compared to the vehicle control. Among these upregulated genes, MED treatment led to a reduction in 1167 genes, including those encoding proinflammatory cytokines such as IL1B, IL6, and IL8. Pathway analysis revealed the enrichment of DEGs in the TNF and NFκB signaling pathway, further supporting the involvement of MED in modulating inflammatory responses. Subsequent experiments demonstrated that MED inhibited the expression of IL6 and IL8 at both the mRNA and protein levels in both SW982 cells and HSF. Additionally, MED treatment resulted in a reduction in p65 phosphorylation in both cell types, indicating its inhibitory effect on NFκB activation. Interestingly, MED also inhibited Akt phosphorylation in SW982 cells, but not in HSF. Overall, our findings suggest that MED suppresses TNFα-mediated inflammatory cytokine production and p65 phosphorylation. These results highlight the potential therapeutic value of MED in managing inflammatory conditions in OA. Further investigations utilizing articular chondrocytes and animal models of OA may provide valuable insights into the therapeutic potential of MED for this disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteoarthritisTumor Necrosis Factor-alphaHumansAnti-Bacterial AgentsCytokinesFibroblastsInflammationInterleukin-6Interleukin-8NaphthoquinonesBenzoisochromanequinones

Stichwörter der Autor:innen

NFκBTNF-αmedermycinosteoarthritissynovial fibroblast

Substanzen

Anti-Bacterial AgentsCytokinesInterleukin-6Interleukin-8Tumor Necrosis Factor-alphamedermycinNaphthoquinonesBenzoisochromanequinones

Autor:innen und Institutionen

  • Department of Orthopedic Surgery, Kitasato University School of Medicine, 1-15-1 Minami-ku Kitasato, Sagamihara City 252-0374, Japan.
  • Graduate School of Infection Control Sciences, Kitasato University, 5-9-1 Minato-ku Shirokane, Tokyo 108-8641, Japan.
  • Ōmura Satoshi Memorial Institute, Kitasato University, 5-9-1 Minato-ku Shirokane, Tokyo 108-8641, Japan.
  • Department of Biochemistry, Kitasato University School of Medicine, 1-15-1 Minami-ku, Kitasato, Sagamihara City 252-0374, Japan.
  • Shonan University of Medical Sciences Research Institute, Nishikubo 500, Chigasaki 253-0083, Japan.

ORCID-Profile: Gen Inoue, Tomoyasu Hirose, Masato Iwatsuki, Masayuki Miyagi, Kentaro Uchida

Förderung

  • JSPS KAKENHI
  • Research Support Project for Life Sciences Research and Drug Discovery, specifically the Basis for Supporting Innovative Drug Discovery and Life Science Resear…
  • All Kitasato Project Study (AKPS)
  • Agency for Medical Research and Development

Zitieren

APA

Inoue, S., Inahashi, Y., Itakura, M., Inoue, G., Muneshige, K., Hirose, T., Iwatsuki, M., Takaso, M., Miyagi, M., & Uchida, K. (2023). Medermycin Inhibits TNFα-Promoted Inflammatory Reaction in Human Synovial Fibroblasts. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241813871

Vancouver

Inoue S, Inahashi Y, Itakura M, Inoue G, Muneshige K, Hirose T, et al. Medermycin Inhibits TNFα-Promoted Inflammatory Reaction in Human Synovial Fibroblasts. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241813871

BibTeX
@article{Inoue2023,
  author = {Inoue, Sho and Inahashi, Yuki and Itakura, Makoto and Inoue, Gen and Muneshige, Kyoko and Hirose, Tomoyasu and Iwatsuki, Masato and Takaso, Masashi and Miyagi, Masayuki and Uchida, Kentaro},
  title = {Medermycin Inhibits TNFα-Promoted Inflammatory Reaction in Human Synovial Fibroblasts},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241813871}
}
Kostenlos starten →